IVUS Assessment in Patients at High Risk of Coronary Occlusion After TAVI: Results from the ICARO Study

Courtesy of Dr. Juan Manuel Pérez.

Acute coronary obstruction (ACO) is a rare but potentially fatal complication following transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve (ViV) procedures. While it can be prevented through the use of chimney stents, their placement is still risky and often proves unnecessary. Angiography, with its limitations regarding the assessment of valve leaflets and coronary ostia, may underestimate the true risk. In this context, intravascular ultrasound (IVUS) emerges as a more precise tool to guide the actual need for stenting.

ICARO, a prospective, multicenter, observational study, included 32 patients (mean age: 83 years; 56.3% women), with a total of 40 coronary vessels considered at high risk of ACO, based on the presence of at least two anatomical criteria identified via CT imaging. In patients undergoing TAVI on native valves (25%), the main findings were low-lying ostia (<9 mm), narrow sinuses of Valsalva (<30 mm in 78.1% on the left side and 84.3% on the right), and valve leaflets extending beyond the left (93.8%) and right (53.1%) coronary ostia.

In ViV procedures (75%), there were unfavorable surgical bioprostheses in 75% of cases (either stentless or with externally mounted leaflets), low left coronary ostium (93.8%), virtual transcatheter heart valve-to-coronary distance (VTC <4 mm) in 65.6% of left vessels and 25% of right vessels, as well as virtual transcatheter heart valve-to-sinotubular junction distance (VT-STJ <3.5 mm) in 59.4% of cases on the left vessels and 15.6% of cases on the right vessels.

The primary aim of the study was to assess the feasibility and safety of IVUS in guiding the need for chimney stent implantation after TAVI. In 38 out of 40 vessels (95%), IVUS was feasible and used without complications. Two patients (5%) required urgent stent implantation due to immediate coronary obstruction following valve deployment.

Read also: Transcatheter Tricuspid Valve Replacement: 1-Year Outcomes.

The use of IVUS resulted in no stent implantation in 63.2% of cases (24 out of 38 vessels). After one year, the incidence of major adverse cardiovascular events (MACE) was 6.2% in both the stented and non-stented groups (p = 0.964). The concordance between angiography and IVUS was 74%, highlighting the higher sensitivity of IVUS in detecting an actual risk for obstruction.

IVUS findings most frequently associated with the need for angioplasty included a minimal luminal area in the ostial-paraostial space <9.5 mm² (p = 0.044), a minimal ostial diameter <3.9 mm (p = 0.005), and a distance between the displaced leaflet and the ostium <3 mm (p = 0.010).

Conclusion

The ICARO study demonstrates that using IVUS after TAVI in patients at high risk of coronary obstruction is a safe, feasible, and clinically valuable strategy for avoiding unnecessary chimney stent implantation, without compromising medium-term clinical outcomes.

Original Title: Intravascular Ultrasound Assessment of Coronary Arteries at High Risk for Obstruction Following TAVR: The ICARO Study.

Reference: Lunardi M., Pesarini G., Cubich M., Dumonteil N., Abdel-Wahab M., Mylotte D., Castriota F., Laforgia P., Fezzi S., Scarsini R., Ribichini F. JACC: Cardiovascular Interventions. 2025;18(9):1147–1160. https://doi.org/10.1016/j.jcin.2025.03.016.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...